SARS-CoV-2 Nucleocapsid Antikörper (AA 121-422)
Kurzübersicht für SARS-CoV-2 Nucleocapsid Antikörper (AA 121-422) (ABIN7469590)
Target
Alle SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 121-422
-
Spezifität
- This antibody detects both SARS-CoV nucleocapsid and SARS-CoV-2 nucleocapsid proteins. Our internal testing indicates no cross-reactivity with MERS-CoV nucleocapsid protein.
-
Kreuzreaktivität
- SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
-
Aufreinigung
- Affinity purified by Protein G.
-
Immunogen
- The immunogen used to generate this antibody corresponds to SARS-CoV Nucleocapsid (121-422 a.a.).
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- WB: 1:1000-1:10000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.5 mg/mL
-
Buffer
- PBS, No Preservative
-
Konservierungsmittel
- Without preservative
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Andere Bezeichnung
- SARS-CoV-2 Nucleocapsid
-
Hintergrund
- 2019-nCoV Nucleocapsid , SARS-CoV-2 Nucleocapsid , COVID-19 Nucleocapsid , 2019-nCoV NP , SARS-CoV-2 NP , COVID-19 NP
Target
-